Levemir

Approved Uses

Levemir is prescribed to help manage blood glucose levels in people with diabetes. It is approved for the following populations:

• Type 1 Diabetes: It is used in adults and children who are at least 2 years of age.
• Type 2 Diabetes: It is used in adults to maintain glycemic control.

Role in Diabetes Management

As a long-acting (basal) insulin, Levemir provides a steady level of insulin in the body for up to 24 hours. It is designed to mimic the background insulin production of a healthy pancreas, helping to keep blood sugar levels stable between meals and overnight. It is often used as part of a comprehensive treatment plan that may also include mealtime insulin or oral diabetes medications.

Mechanism of Action

Levemir (insulin detemir) works by replacing the insulin that the body would normally produce. Insulin is a hormone that allows sugar (glucose) in the blood to enter cells, where it is used for energy.

When injected, Levemir helps manage blood sugar in two main ways:

• It signals muscle and fat cells to absorb glucose from the bloodstream.
• It signals the liver to stop producing and releasing additional glucose into the blood.

Long-Acting Profile

Levemir is classified as a long-acting or basal insulin. After it is injected under the skin, it is absorbed slowly into the bloodstream. This slow release provides a relatively steady level of insulin for up to 24 hours, helping to maintain stable blood sugar levels between meals and during sleep.

Common Side Effects

The most frequent side effect of Levemir is hypoglycemia (low blood sugar). Other common side effects may include:

• Injection site reactions: Redness, pain, itching, or swelling where the insulin was injected.
• Weight gain: This is common with many insulin therapies.
• Lipodystrophy: Changes in skin thickness, lumps, or pits at the injection site.
• General symptoms: Headache, back pain, or symptoms of a common cold or flu.

Serious Side Effects

Some side effects can be severe and require immediate medical attention. These include:

• Severe hypoglycemia: Symptoms may include extreme confusion, seizures, or loss of consciousness.
• Severe allergic reactions: Signs include a whole-body rash, trouble breathing, fast pulse, sweating, or swelling of the face, tongue, or throat.
• Low potassium (hypokalemia): Symptoms may include muscle cramps, weakness, or an irregular heartbeat.
• Heart failure: When used with certain other diabetes medications called thiazolidinediones (TZDs), Levemir may increase the risk of heart failure. Symptoms include shortness of breath and swelling of the ankles or feet.

Hypoglycemia

Low blood sugar (hypoglycemia) is the most common side effect of insulin therapy. Severe hypoglycemia can cause seizures, unconsciousness, or death. Monitoring blood glucose levels is essential, especially when changing insulin doses, co-administered medications, or meal patterns.

Hypokalemia

All insulin products, including Levemir, cause a shift in potassium from the blood into the cells. This can lead to low potassium levels (hypokalemia). If left untreated, this may result in respiratory paralysis, heart rhythm problems, or death. Monitoring is particularly important for patients at risk, such as those using potassium-lowering medications.

Allergic Reactions

Severe, life-threatening, generalized allergy, including anaphylaxis, can occur. Symptoms may include rash, itching, shortness of breath, wheezing, fast pulse, or sweating. If a serious reaction occurs, the medication must be discontinued immediately.

Fluid Retention and Heart Failure

Using Levemir in combination with certain diabetes medications called thiazolidinediones (TZDs) may cause fluid retention and heart failure, even in people without prior heart problems. Patients should be monitored for signs such as shortness of breath, swelling of the ankles or feet, and sudden weight gain.

Medication Errors

To prevent the spread of germs, Levemir FlexPens or syringes should never be shared between people, even if the needle is changed. Additionally, patients must always check the insulin label before injection to avoid accidental mix-ups between Levemir and other insulin products.

Pregnancy

Maintaining stable blood sugar levels is critical during pregnancy to prevent complications such as birth defects, pregnancy-induced hypertension, or issues for the newborn. Clinical studies have shown that insulin detemir does not appear to increase the risk of fetal harm or birth defects compared to other insulin products like NPH insulin.

Insulin needs typically change throughout the course of a pregnancy. Dosage requirements may decrease during the first trimester and significantly increase during the second and third trimesters. Close monitoring by a healthcare professional is necessary to manage these changes and ensure the health of both the parent and the baby.

Breastfeeding

Levemir is generally considered safe to use while breastfeeding. Because insulin is a natural hormone, any small amounts that pass into breast milk are likely to be broken down in the infant's digestive system. However, breastfeeding itself can lower blood sugar levels, and insulin requirements may decrease after delivery. Healthcare providers often recommend adjusting the dose and monitoring glucose levels closely during this period.

Available Forms

Levemir is supplied as a sterile, clear, colorless solution for subcutaneous injection. It is available in the following delivery systems:

• Multi-dose vial: A glass vial used for withdrawing the solution with a syringe.
• Prefilled pen: A disposable, single-patient-use device, such as the FlexTouch or FlexPen, used for insulin delivery.

These delivery systems are used to administer the medication into the subcutaneous tissue of the thigh, abdominal wall, or upper arm.

FDA Approval and Indications

Levemir (insulin detemir) is FDA-approved for the treatment of diabetes mellitus in adults and pediatric patients. It is indicated for both type 1 and type 2 diabetes to help maintain stable blood sugar levels over a 24-hour period.

Product Discontinuation

The manufacturer has announced that Levemir is being discontinued in the United States market. The timeline for this phase-out includes:

• Levemir FlexPen: Discontinued as of April 2024.
• Levemir Vials: Expected discontinuation by June 2024.

The discontinuation is reportedly due to manufacturing constraints and the availability of alternative treatments rather than safety or efficacy concerns. Patients are advised to consult their healthcare providers to transition to alternative long-acting insulin therapies.

Safety Monitoring

The FDA has monitored reports of potential medication errors involving Levemir. A specific safety signal was identified regarding name confusion between Levemir and Lenvima, a medication used for cancer treatment. Regulatory authorities track these reports to ensure labeling and packaging minimize the risk of patients receiving the wrong medication.

There are currently no boxed warnings or Risk Evaluation and Mitigation Strategy (REMS) requirements associated with Levemir.

Factors Affecting Cost

The out-of-pocket price for Levemir can vary based on several key factors:

• Formulation: Levemir is available in two delivery systems: a 10 mL multi-dose vial and a 3 mL pre-filled FlexPen. The cost may differ between these two options depending on the pharmacy and insurance plan.
• Dosage: Since Levemir is a long-acting insulin typically injected once or twice daily, the total amount of insulin required for your specific treatment plan will determine how frequently you need to refill the medication.
• Insurance Coverage: Most commercial insurance plans and Medicare Part D provide coverage for Levemir. However, the drug's placement on a plan's formulary (tier level) will dictate the copay or coinsurance amount.

Financial Assistance and Savings

For those without insurance or those with high deductibles, there may be options to reduce costs. Manufacturer-sponsored patient assistance programs and savings cards are often available for eligible patients. Additionally, prices can vary between retail pharmacies, so comparing costs at different locations or using mail-order services may result in savings.